199 related articles for article (PubMed ID: 22257918)
1. Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab.
Azevedo VF; Paiva E; Tosin T; Ferreira A; Ferreira AM; Fernandes M
Reumatismo; 2011 Nov; 63(3):171-4. PubMed ID: 22257918
[TBL] [Abstract][Full Text] [Related]
2. [Pulmonary tuberculosis associated to adalimumab: a study of 3 cases].
Blanco Pérez JJ; Aranda Torres A; Pego Reigosa JM; Núñez Delgado M; Temes Montes E; Guerra Vales JL
Arch Bronconeumol; 2010 Apr; 46(4):203-5. PubMed ID: 19896259
[TBL] [Abstract][Full Text] [Related]
3. Tuberculous myositis in a patient with ankylosing spondylitis treated with adalimumab.
Azevedo VF; Parchen C; Coelho SA; Lacerda DC; Hirth CG
Rheumatol Int; 2009 Sep; 29(11):1381-4. PubMed ID: 19142641
[TBL] [Abstract][Full Text] [Related]
4. Multiple organ tuberculosis of lung, pleura, and peritoneum in ankylosing spondylitis during adalimumab therapy.
Yoo WH
Rheumatol Int; 2012 Mar; 32(3):787-90. PubMed ID: 20049444
[TBL] [Abstract][Full Text] [Related]
5. Mucocutaneous leishmaniasis in a patient treated with anti-TNF-α therapy.
Garcia-Gonzalez E; Guidelli GM; Bardelli M; Maggio R
Rheumatology (Oxford); 2012 Aug; 51(8):1517-8. PubMed ID: 22427411
[No Abstract] [Full Text] [Related]
6. [Occurrence of vitiligo in a patient with ankylosing spondylitis receiving adalimumab].
Toussirot E; Salard D; Algros MP; Aubin F
Ann Dermatol Venereol; 2013 Dec; 140(12):801-2. PubMed ID: 24315228
[No Abstract] [Full Text] [Related]
7. Acute renal failure in patient treated with anti-tumour necrosis factor alpha.
Justo Ávila P; Gracia Iguacel C; Ortiz Arduán A; Martín-Cleary C; Acuña Ramos M; Sainz Prestel V; Rodríguez-Osorio L; Barat Cascante A; Santonja C; Egido J
Nefrologia; 2011; 31(4):484-8. PubMed ID: 21738251
[No Abstract] [Full Text] [Related]
8. Cutaneous leishmaniasis in a patient with ankylosing spondylitis using adalimumab.
Gomes KW; Benevides AN; Vieira FJ; Burlamaqui MP; Vieira Mde A; Fontenelle LM
Rev Bras Reumatol; 2012; 52(3):447-52. PubMed ID: 22641598
[TBL] [Abstract][Full Text] [Related]
9. Morphea associated with the use of adalimumab: a case report and review of the literature.
Ramírez J; Hernández MV; Galve J; Cañete JD; Sanmartí R
Mod Rheumatol; 2012 Aug; 22(4):602-4. PubMed ID: 22095405
[TBL] [Abstract][Full Text] [Related]
10. [Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report].
Azevedo VF; Pietrovski CF; de Almeida Santos M
Reumatismo; 2010; 62(4):283-5. PubMed ID: 21253622
[TBL] [Abstract][Full Text] [Related]
11. [Non tuberculous anti-TNF associated opportunistic infections].
Marie I; Guglielmino E
Rev Med Interne; 2010 May; 31(5):353-60. PubMed ID: 20381217
[TBL] [Abstract][Full Text] [Related]
12. Disseminated tuberculosis secondary to adalimumab.
Pednekar M; Chandra AB; Chandra PA
Am J Ther; 2012 Jul; 19(4):e139-40. PubMed ID: 20838203
[TBL] [Abstract][Full Text] [Related]
13. Multiple paradoxical adverse events in a patient affected with ankylosing spondylitis treated with TNF blockers.
Lo Nigro A; Ramonda R; Alaibac M; Modesti V; Punzi L
Eur J Dermatol; 2011; 21(2):263-4. PubMed ID: 21411412
[No Abstract] [Full Text] [Related]
14. Lichen planus under anti TNF therapy for ankylosing spondylitis.
Wendling D; Biver-Dalle C; Vidon C; Prati C; Aubin F
Joint Bone Spine; 2013 Mar; 80(2):227-8. PubMed ID: 23453473
[No Abstract] [Full Text] [Related]
15. [Case of rheumatoid arthritis presenting with pulmonary tuberculosis].
Katoh K; Taniguchi H; Okouchi A; Kudo M; Kawai T
Nihon Kokyuki Gakkai Zasshi; 2004 Aug; 42(8):782-6. PubMed ID: 15455955
[TBL] [Abstract][Full Text] [Related]
16. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
17. Possible miliary tuberculosis during adalimumab therapy with negative gamma-IFN release assays.
Endean AL; Barry SM; Young-Min SA
Rheumatology (Oxford); 2009 Mar; 48(3):319-20. PubMed ID: 19109314
[No Abstract] [Full Text] [Related]
18. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
[TBL] [Abstract][Full Text] [Related]
20. Reversible male infertility under treatment with an anti-TNFα agent: a case report.
Wildi LM; Haraoui B
Ann Rheum Dis; 2012 Mar; 71(3):473-4. PubMed ID: 22138196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
